Trials / Conditions / Premenopausal Breast Cancer

Premenopausal Breast Cancer

13 registered clinical trials studyying Premenopausal Breast Cancer — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Gen NCT07106632	UNICANCER	Phase 3
Recruiting	Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Pa NCT06225284	National Taiwan University Hospital	Phase 2
Unknown	Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian F NCT05801705	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	—
Recruiting	Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Section NCT06458764	Candiolo Cancer Institute - IRCCS	—
Recruiting	OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk NCT05333328	Gangnam Severance Hospital	Phase 4
Active Not Recruiting	Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer NCT05982093	SOLTI Breast Cancer Research Group	Phase 2
Recruiting	Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC NCT05720260	National Taiwan University Hospital	Phase 2
Active Not Recruiting	Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients NCT04997941	Seoul National University Hospital	Phase 2
Completed	Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer NCT03407768	University of Saskatchewan	N/A
Terminated	Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Can NCT02990845	National Taiwan University Hospital	Phase 1 / Phase 2
Completed	Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer" NCT03209518	Takeda	—
Terminated	Ovarian Reserve in Premenopausal Breast Cancer NCT01726322	Cancer Trials Ireland	—
Completed	A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premeno NCT01546649	Takeda	Phase 3